FAST Congress
2013 Archived Content

2013 Distinguished Faculty 



John L. Allinson, FIBMS, Vice President, Biomarker Laboratory Services, ICON Development Solutions

Nazneen Aziz, Ph.D., Director, Molecular Medicine, Transformation Program Office, College of American Pathologists

Darrell R. Borger, Ph.D., Co-Director, Translational Research Laboratory; Director, Biomarker Laboratory, Massachusetts General Hospital Cancer Center

Kierstyn Claycomb, Senior Manager, Business Development, Companion Diagnostics, Asuragen

Carol Cheung, M.D., Ph.D., Department of Pathology, University Health Network, Canada

Franklin Cockerill, M.D., Chair, Laboratory Medicine and Pathology, Mayo Clinic

Carolyn Compton, M.D., Ph.D., Professor, School of Life Sciences, Arizona State University

Mark Connelly, Ph.D., Scientific Director, Janssen R&D

Seth Crosby, M.D., Director, Partnerships & Alliances, Washington University School of Medicine

Michael Cummens, M.D., CMO, Remedy Informatics, Inc.

Nicholas C. Dracopoli, Ph.D., Vice President, Janssen R&D, Johnson & Johnson

Andrea Ferreira-Gonzalez, Ph.D., Professor and Chair, Division of Molecular Diagnostics; Director, Molecular Diagnostics Laboratory, Department of Pathology, Virginia Commonwealth University

David A. Fenstermacher, Ph.D., Chief Research Information Officer, Virginia Commonwealth University

Dai Fukumura, M.D., Ph.D., Associate Professor, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School

Stephen T. Furlong, Ph.D., Safety Science Lead, AstraZeneca

Harry Glorikian, Managing Director, Precision for Medicine

Federico Goodsaid, Ph.D., Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals

Martina Kaufmann, Ph.D., International Projects Director, Integrated Medicines, Ltd.

Chetan Lathia, Ph.D., Executive Director, Clinical Pharmacology, Alexion Pharmaceuticals

Richard Levenson, M.D., Professor and Vice Chair for Strategic Technologies, Department of Pathology & Laboratory Medicine, University of California, Davis Medical Center

Sylvie le Gledic, Director, Personalized Medicine, Voisin Consulting

Ron Mazumder, Ph.D., MBA, Global Head, Research and Product Development, Janssen Diagnostics, Janssen Pharmaceutical Companies of Johnson & Johnson

Robert S. McDonough, M.D., Head, Clinical Policy Research & Development, Aetna

Scott McKeown, Ph.D., Research & Development Consultant, Randox Laboratories, Ltd.

Yoshiya Oda, Ph.D., President, Biomarkers and Personalized Medicine Core Function Unit, Eisai

Kalle Ojala, Ph.D., Chief Product Officer, MediSapiens, Ltd.

David Parker, Ph.D., Vice President, Market Access Strategy, Precision for Medicine

Hans Christian Pedersen, MSc, Principal Scientist, Research & Development, PharmDx, Dako

Kathryn A. Phillips, Ph.D., Professor, Health Economics and Health Services Research; Director, UCSF Center for Translational and Policy Research on Personalized Medicine, University of California, San Francisco

Oscar Puig, Ph.D., Biomarker Experimental Medicine Leader, Roche

S. Michael Rothenberg, M.D., Ph.D., Instructor, Medicine, Massachusetts General Hospital

Afshin Safavi, Ph.D., Senior Vice President, Bioanalytical Operations, BioAgilytix Labs

Martin Schwickart, Ph.D., Scientist, Clinical Pharmacology and DMPK, MedImmune

Dominic Sinibaldi, Ph.D., Scientific Manager, R&D IS Clinical Informatics, MedImmune

Judi Smith, Vice President, in vitro Diagnostics & Quality, Precision for Medicine

Morten Sogaard, Ph.D., Executive Director and Head, Biotechnology and Precision Medicine, External R&D Innovation, Worldwide R&D, Pfizer

Apostolia-Maria Tsimberidou, M.D., Ph.D., Associate Professor, Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center

George Vasmatzis, Ph.D., Assistant Professor, Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic

Kimberly Walter, Ph.D., Senior Research Assistant, Genentech

Amelia Warner, Ph.D., President, Gentris Corp.

Shane Weber, Ph.D., Director, Diagnostics, Clinical Research and Precision Medicine, Pfizer

Alan T. Wright, M.D., MPH, CMO, Roche Diagnostics Corporation

Theresa Zhang, Ph.D., Associate Director, Exploratory and Translational Sciences, Merck